多機能ヒドロゲルは,鉄のバランスとエネルギー代謝を改造することによって,糖尿病の傷の治癒を促進します
Chen Jin1, Yu-Zhe Lin2, Ri-Yan Zhang3
1Department of Wound healing, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), National Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China; Department of Orthopaedics, Zhejiang Provincial Key Laboratory of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
Biomaterials
|August 23, 2025
まとめ
この研究はフェロプトーシスが 糖尿病の傷の治癒を促すことを示しています 新しいヒドロゲル (TC@BS) は,フェロプトーシスを抑制し,血管形成を促進し,治癒を加速させることで,糖尿病の傷をうまく治療しました.
科学分野:
- 生物医学工学
- 再生医療
- 細胞生物学
背景:
- 糖尿病患者は,内皮細胞機能障害と過剰な鉄分により,傷の治癒が遅れている.
- 鉄に依存する細胞死であるフェロプトーシスは糖尿病の合併症と関連しているが,高血糖症による血管新生におけるその役割は不明である.
研究 の 目的:
- 糖尿病の創傷治癒と血管新生におけるフェロプトーシスの役割を調査する.
- フェロプトーシスを調節するヒドロゲルを開発して 糖尿病の傷を修復する
主な方法:
- 糖尿病足の潰瘍 (DFU) と高血糖状態による内皮細胞における特徴的なフェロプトーシス.
- "ダブルシンク"戦略を用いたフェロプトーシス調節ヒドロゲル (TC@BS) を設計し,試験した.
- STZ誘発の糖尿病マウス創傷モデルにおけるTC@BSの有効性を評価した.
主要な成果:
- 反応性酸素種 (ROS) が増加し,ミトコンドリアの機能が低下した糖尿病の内皮細胞でフェロプトーシスに関連した代謝現象を特定した.
- TC@BSは鉄をケラートし,脂質過酸化を減らし,ミトコンドリア機能を保ち,フェロプトーシスを効果的に抑制しました.
- TC@BSは糖尿病の傷の治癒を著しく加速し,新血管化を改善し,体内の鉄の蓄積を減少させた.
結論:
- フェロプトーシスは 糖尿病の傷の治癒を阻害する重要な要因です
- TC@BSヒドロゲルは 糖尿病の傷に対するフェロプトーシス中心の 再生戦略を提供しています
- PI3K/Aktシグナリングは,鉄が豊富な糖尿病の傷の微小環境におけるフェロプトーシスの抑制に不可欠である.
関連する概念動画
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
953
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
953
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
01:31Diabetic Foot Ulcer
33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59